Max Gill

Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries

Guy De Backer, Piotr Jankowski, Kornelia Kotseva et al. · Atherosclerosis · 2019 · 369 citations · Full text

Medicine, Cardiology, Internal Medicine +14

Screening for Glucose Perturbations and Risk Factor Management in Dysglycemic Patients With Coronary Artery Disease—A Persistent Challenge in Need of Substantial Improvement: A Report From ESC EORP EUROASPIRE V

Giulia Ferrannini, Dirk De Bacquer, Guy De Backer et al. · Diabetes Care · 2020 · 79 citations · Full text

Medicine, Cardiology, Internal Medicine +15

Clinical and economic benefits of professional CGM among people with type 2 diabetes in the United States: analysis of claims and lab data

Joseph A. Sierra, Mona Shah, Max Gill et al. · Journal of Medical Economics · 2017 · 38 citations · Full text

Pharmacy, Internal Medicine, Pharmacoeconomics +17

Impact of Reducing Glycated Hemoglobin on Healthcare Costs Among a Population with Uncontrolled Diabetes

Megha Bansal, Mona Shah, Brian K. Reilly et al. · Applied Health Economics and Health Policy · 2018 · 35 citations

Medicine, Internal Medicine, Pharmacoeconomics +16

Health Care Costs, Hospital Admissions, and Glycemic Control Using a Standalone, Real-Time, Continuous Glucose Monitoring System in Commercially Insured Patients With Type 1 Diabetes

Max Gill, Cyrus Zhu, Mona Shah et al. · Journal of Diabetes Science and Technology · 2018 · 23 citations · Full text

Medicine, Internal Medicine, Pharmacoeconomics +17